# The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

> **NCT01656057** · NA · COMPLETED · sponsor: **Filip Krag Knop** · enrollment: 10 (actual)

## Conditions studied

- To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion

## Interventions

- **DRUG:** Acetaminophen
- **DRUG:** Metformin
- **DRUG:** Colesevelam
- **OTHER:** Cholecystokinin-8
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT01656057
- **Lead sponsor:** Filip Krag Knop
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-10
- **Final completion:** 2014-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01656057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01656057, "The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01656057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*